Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma.
Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses.
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.
Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals.
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes.
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.
A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design.
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity.
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.
Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.
Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001.
Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity.
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity.